Artelo Biosciences: reports Nasdaq $5,000,000 MVLS rule developments

What happened The filing says the Securities and Exchange Commission approved The Nasdaq Stock Market LLC’s new listing compliance rule requiring a market value of listed securities of at least $5,000,000 on Jul 22, 2026. The filing reports that approximately 180 companies were initially identified as having an MVLS below the new threshold, including Artelo Biosciences, Inc. On Jul 29, 2026, the filing says a temporary stay of the $5,000,000 MVLS rule was announced. The filing also reports that on Oct 5, 2026 the SEC published a notice from Nasdaq for a proposed rule change to modify the operative date of the rule, with comments due by Oct 29, 2026.

Key details

• The rule requires listed companies to maintain an MVLS of at least $5,000,000.
• Approximately 180 companies were initially identified as below the $5,000,000 threshold, including Artelo Biosciences.
• A temporary stay of the rule was announced on Jul 29, 2026; on Oct 5, 2026 the SEC published Nasdaq’s proposed rule change and comments are due by Oct 29, 2026.
• The filing says the company may consider steps to regain or maintain compliance if the rule takes effect, including raising capital through its existing at-the-market equity offering program or other equity or equity-linked financings, actions with respect to outstanding warrants or other securities, advancing development programs, managing operating expenses, and other corporate actions; the company has not committed to any particular course of action.

Why it may matter The filing was made under Item 8.01, Other events, which covers disclosure of other developments the company considers material. The filing says the company is monitoring developments and has no information about the duration of the stay, whether the rule will be reinstated as currently written, or whether modifications will be adopted. A filing does not show why the insider traded or why the company acted.